Nimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancer | |
Wang, Hua-qing; Ren, Yangang; Qian, Zheng-zi; Fu, Kai; Zhang, Hui-lai; Li, Wei; Hou, Yun; Zhou, Shi-yong; Hao, Xi-shan; Xie, Cong-hua | |
刊名 | THORACIC CANCER |
2012 | |
卷号 | 3期号:1 |
关键词 | Advanced non-small-cell lung cancer combined therapy nimotuzumab second-line chemotherapy |
ISSN号 | 1759-7706 |
DOI | 10.1111/j.1759-7714.2011.00083.x |
URL标识 | 查看原文 |
收录类别 | SCIE |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4049626 |
专题 | 武汉大学 |
推荐引用方式 GB/T 7714 | Wang, Hua-qing,Ren, Yangang,Qian, Zheng-zi,et al. Nimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancer[J]. THORACIC CANCER,2012,3(1). |
APA | Wang, Hua-qing.,Ren, Yangang.,Qian, Zheng-zi.,Fu, Kai.,Zhang, Hui-lai.,...&Xie, Cong-hua.(2012).Nimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancer.THORACIC CANCER,3(1). |
MLA | Wang, Hua-qing,et al."Nimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancer".THORACIC CANCER 3.1(2012). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论